The Organ Company

The cell knows
how to build
organs.

Every embryo proves it. We are building the tools to watch it happen, understand the constraints it navigates, and enforce those constraints on demand.

600,000+ patients on transplant waiting lists
80+ deaths per day waiting
30 yrs of organ engineering research
0 transplantable solid organs built

We've been engineering endpoints, not trajectories.

Thirty years of organ bioengineering has focused on the parts list: better scaffolds, better cell sources, better bioinks. These are real advances. They are not the bottleneck.

The bottleneck is that we cannot monitor or guide the dynamic process of self-organization as it unfolds. The critical early decisions that propagate into divergent developmental outcomes happen in the first hours of organoid development. By the time morphological failure is visible, it cannot be corrected.

The genome did not evolve to specify every cell's state. It evolved to shape a landscape of constraint such that self-organization is reliable.

Creode reads that landscape from trajectory data. It maps the fate decision points and it enforces the topology using a combination of genetic and physical engineering. Keeping developing tissue within the productive chreode, allowing the cells' own capacity to do what it has always known how to do.

Biological reliability comes from constraints, not components.

At the molecular level, gene expression is irreducibly noisy. The TNF-NF-κB pathway transmits roughly 0.92 bits per cell per timepoint. This is barely enough to distinguish signal from silence. Yet most embryos produces hands with five fingers in the right place.

The resolution of this paradox is not genetic determinism. It is the topology of the regulatory network. The constraint architecture that makes certain developmental trajectories stable attractors regardless of molecular fluctuations along the way.

This is what Waddington called the creode (chreode): the necessary path. Not a specification of every molecular event, but the shape of the landscape that makes certain outcomes inevitable. Creode's job is to measure that shape, reconstruct it empirically from single-cell trajectory data, and use it to guide tissue self-organization at therapeutic scale.

The platform

Measure. Map. Enforce.

01 — Measure

The cellular panopticon

A layered measurement architecture spanning milliseconds to weeks. Genetically encoded biosensors for signaling dynamics. Metabolic labeling for transcriptional rates. Protein assembly recorders for multi-week transcription factor histories. All registered to the same cells, the same spatial coordinates, the same developmental timeline.

02 — Map

Empirical landscape reconstruction

From trajectory data, we reconstruct the Waddington landscape as a measurable object. Bifurcation points, noise structure and the topology of constraint mimicking real tissue are defined as engineerable components.

03 — Enforce

Feedback control of self-organization

Real-time monitoring of developing tissue feeds a predictive controller that adjusts growth factor gradients, mechanical boundary conditions, and optogenetic stimuli. This maintains the boundary conditions that keep self-organization on the productive trajectory.

If you work in organoid engineering, dynamical systems, tissue fabrication, or developmental biology and think this problem is the right one to be working on, reach out!

General enquiries hello@creode.bio
Location Basel, Switzerland
Founder Ahmed Moselhi  —  @AhmedMoselhi2